Oncology Providers' Perspectives on Psychedelic-Assisted Therapy.
The American journal of hospice & palliative care August 28, 2026 Krishna S Hanubal, Akul N Munjal, Jino Park et al.
PurposeDespite most psychedelic substances remaining Schedule I, clinical research exploring psychedelic-assisted therapy (PAT) in oncology is expanding. We sought to assess oncology providers' attitudes toward and understanding of PAT.MethodsWe conducted a cross-sectional survey of healthcare professionals involved in oncology across five academic institutions in California, South Carolina,...